Interaction between filovirus glycoprotein (GP) and the Niemann-Pick C1 26 (NPC1) protein is essential for membrane fusion during virus entry. Some single-27 nucleotide polymorphism (SNPs) in two surface-exposed loops of NPC1 are known to 28 reduce viral infectivity. However, the dependence of differences in entry efficiency on 29 SNPs remains unclear. Using vesicular stomatitis virus pseudotyped with Ebola and 30 Marburg virus GPs, we investigated the cell-to-cell spread of viruses in cultured cells 31 expressing NPC1 or SNP derivatives. Eclipse and virus-producing phases were 32 assessed by in vitro infection experiments, and we developed a mathematical model 33 describing spatial-temporal virus spread. This mathematical model fit the plaque 34 radius data well from day 2 to day 6. Based on the estimated parameters, we found 35 that SNPs causing the P424A and D508N substitutions in NPC1 most effectively 36 reduced the entry efficiency of Ebola and Marburg viruses, respectively. Our novel 37 approach could be broadly applied to other virus plaque assays. 3 38 Author Summary 39 Ebola virus belongs to the family Filoviridae, together with Marburg virus and 40 Cueva virus. In 2015, the World Health Organization included Ebola and Marburg 41 viruses among the infectious diseases that should be globally prioritized because 42 these filoviruses can cause severe hemorrhagic fever in humans and nonhuman 43 primates, and antiviral agents to these viruses are very limited. Filovirus particles bear 44 the envelope glycoprotein (GP), which is the only viral surface protein and thus 45 responsible for receptor binding and membrane fusion. Interaction between filovirus 46 GP and the Niemann-Pick C1 (NPC1) protein is essential for membrane fusion during 47 virus entry. Some single-nucleotide polymorphism (SNPs) in two surface-exposed 48 loops of NPC1 are known to reduce viral infectivity. However, the dependence of 49 differences in entry efficiency on SNPs remains unclear. In this study, combining in 50 vitro experiments and mathematical models, we evaluated on the interaction between 51 GP and wildtype and mutant NPC1, enabling us to estimate the cellular entry efficiency 52 during plaque formation. 4 53 55 Marburg (MARV) viruses among the infectious diseases that should be globally 56 prioritized. Some viruses of the family Filoviridae, which includes EBOV and MARV, 57 cause severe hemorrhagic fever in humans and nonhuman primates. In recent years, 58 more frequent filovirus outbreaks have been observed including multiple introductions 59 of filoviruses into the human population, with important implications for worldwide 60 public health [1] 61 Filovirus particles bear the envelope glycoprotein (GP), which is the only viral 62 surface protein and thus responsible for receptor binding and membrane fusion [2]. 63 Filovirus infection is initiated by binding of GP to attachment factors such as C-type 64 lectins [3, 4], T-cell immunoglobulin and mucin domain 1 (TIM-1) and C-type lectins 65 [5]. Virus particles are internalized into host cells via macropinocytosis and then 66 delivered to late endosomes [6, 7]. GPs are proteolytically processed by cysteine 67 proteases such as cathepsins B and L [8, 9]. This digested GP (dGP) can interact 68 with the host endosomal fusion receptor, Niemann-Pick C1 (NPC1) protein, allowing 69 fusion between the viral envelope and the host endosomal membrane [10, 11]. NPC1
Introduction 54
In 2015, the World Health Organization (WHO) included Ebola (EBOV) and
116 Because the infectious phase was relatively long compared with the duration of 117 the eclipse phase, we assumed that the infectious phase follows the Erlang distribution 118 as described previously [19, 20] . The equivalence between the expression for, and the 119 parameters of, the probability density functions of the Erlang distributions is shown as 120 follows [21] :
The shape ( and ) and scale ( and ) = = 123 364 = = 8.64 × 10 -3 3.10 × 10 -3 123 parameters of the Erlang distribution for VSV∆G-EBOV and VSV∆G-MARV were 124 estimated by fitting the candidates for the infectious phase, respectively ( Table 1) .
125 Note that and correspond to the number of "subdivided" compartments and the 126 average duration of the infectious phase, respectively, in Eq.(4) [20, 21] (see later) .
127 The probability density functions of the estimated Erlang distributions of infectious 128 phases are shown in the right panels of Fig.1A and B . Conversely, we assumed that 129 the eclipse phase with relatively short duration follows an exponential distribution as 130 in many basic virus dynamics models [22] [23] [24] . We planned to quantify the eclipse 131 phase for VSV∆G-EBOV and VSV∆G-MARV from the results of plaque assays 132 together with other parameters (see later).
133
134 Spatial-temporal mathematical model for viral plaque amplification
135
To quantify and compare the filovirus entry efficiency among cells expressing 136 wildtype and SNP-mutant NPC1, we performed viral plaque assays using cells 137 expressing wildtype NPC1 (293T-NPC1) and five SNP mutants for VSV∆G-EBOV and 138 VSV∆G-MARV ( Fig.1C and D) . The viral plaque is considered as the area formed by 139 dead cells, and thus the plaque radius is defined by the distance from the center of 140 plaque to its edge. We measured the average sizes of independent plaques (see 141 Methods) and used them to quantify spatial-temporal VSV∆G-EBOV and VSV∆G-142 MARV spread. First, we developed a novel mathematical model for viral plaque 143 amplification as follows. Because monolayers of cells were overlaid with agar media 144 in our plaque assay, there was no cell movement. Only cell-to-cell infections between 145 infected and adjacent uninfected cells occur. We assumed that the inner infected cell 146 infects only adjacent outer target cells ( Fig.2A ). To describe the infection dynamics of 147 virus in the plate, we derived the following mathematical model including two 148 independent variables (time and radius of circle ) and four state variables 149 (uninfected, eclipse phase, infectious phase and dead cells):
150
( , ) =-
151 The initial conditions were: for and for , 1 (0, ) = 2 × /0.008 ≤ 0 0 > 0 (0, ) = 0 152 for and for , and for . Here , ≤ 0 2 × /0.008 > 0 (0, ) = (0, ) = 0 > 0 ( , )
153
, and represent the numbers of uninfected, eclipse phase, infectious ( , ) ( , ) ( , )
154 phase and dead cells, respectively. Note that Eq. (4) is derived from the following 155 integro-differential equation by "linear-chain-trick" which is discussed in detail 156 elsewhere [25-27]:
157
158 We also assumed that infectious cells of the compartment were inoculated only in 1 159 a radius of less than and there were no other infected cells at the initial time. The 172 that is, . Since the radius of each circle line increases proportionally to the 2 /0.008 173 cell interval ( mm), total cell number in the plate can be calculated as 0.008
174
, and was consistent with the number of cells ∑ 2169 = 1 2 × 0.008 × /0.008 = 1.779 × 10 7 175 used in our experiments.
176
Using a finite difference method, we computed a numerical solution of Eqs. (1- 179 Dead cells (black line) are located at a radius of 0.8 mm from the center of the plaque 180 which is considered as "a plaque radius" in our simulation. That is, we defined the 215 snapshots. In Supplementary Movie 1 and 2, we also showed how two and three 216 plaques merge in a spatial-temporal manner. Table 1 and the viral entry efficiency, , is shown in Fig.3B . In the case of 227 VSV∆G-MARV, the entry efficiencies into wildtype and mutant NPC1-expressing cells 228 were similar. Indeed, the entry efficiencies of NPC1 mutants were slightly greater than 229 that of 293T-NPC1 except for the D508N and Y420S substitutions, which had the 230 highest entry efficiency (15% above wildtype). In the case of VSV∆G-EBOV, the 231 P424A, S425L, and D508 substitutions in NPC1 resulted in lower entry efficiencies 232 than 293T-NPC1. The P424A substitution showed the lowest entry efficiency (47% 233 reduction compared with 293T-NPC1). In contrast, the D502E substitution, which had 234 the highest entry efficiency among the NPC1 mutants for VSV∆G-EBOV, 235 demonstrated 26% higher entry efficiency than wildtype NPC1 (discussed below).
Discussion

237
In general, plaque formation is affected by multiple processes including viral 
253
We developed a simple but well approximated mathematical model, i.e., Eqs.
254
(1-5), that can analyze plaque assay data with minimal assumptions to quantitatively 255 compare and analyze the virus entry efficiency by focusing on the interactions between 256 GP and NPC1. VSVΔG-EBOV and VSVΔG-MARV usually grow in cultured cells as 257 well as VSV (taking several hours to produce cytopathic effect (CPE)), whereas EBOV 299 and MARV (Angola) GPs (VSV G-EBOV and VSV G-MARV, respectively) were ∆ ∆ 300 generated as described previously [40] . VSV G-EBOV and VSV G-MARV were ∆ ∆ 301 propagated in Vero E6 cells and stored at -80°C until use. Infectivity of the viruses in 302 each cell line was determined by a plaque-forming assay as described previously [41] .
303 All work using these viruses was performed in the BSL-3 laboratories at the Research and are the mean and standard deviation of the plaque radius in experiments, SD 342 respectively, and is the radius of the plaque in our simulation at day . = 2,3,…,6
343 Using estimated and in the virus production assay, we estimated the parameters 344
and for VSV∆G-EBOV and VSV∆G-MARV, and the common initial value of from 0 345 the plaque assay with 293T-NPC1. With these estimated parameters, we quantified 346 the viral entry efficiency, , for VSV∆G-EBOV and VSV∆G-MARV from the plaque 347 assay with amino acid mutations in NPC1 (D502E, D508N, P424A, S425L and Y420S).
348 All estimated parameters are summarized in Table 1 and Fig.4B . 
